methotrexate improves long-term SURVIVAL in rheumatoid arthritis patients
May 2002
Exciting new research suggests that methotrexate improves long-term SURVIVAL in rheumatoid arthritis patients.
It's well known that methotrexate slows the progression of RA... but it seems to improve survival by reducing cardiovascular deaths.
RA patients have an increased risk of heart disease. It's thought that some of the same inflammation that causes joint damage might also lead to atherosclerosis and heart disease.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote